Research And Markets Research And Markets
0 CHECKOUT

The Pharmaceutical Market: Singapore

  • ID: 45285
  • May 2012
  • Region: Asia, Singapore
  • 62 pages
  • Espicom Business Intelligence Ltd
1 of 4

FEATURED COMPANIES

  • Aventis
  • GlaxoSmithKline
  • Merck AG
  • MerLion Pharmaceuticals
  • Pfizer
  • Wyeth
  • MORE

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

Executive Summary

THE PHARMACEUTICAL MARKET: SINGAPORE - REVIEW

Singapore remains a popular destination for companies using the country as a trading base for the South East Asian region. Incentives such as low corporate tax rates and strong intellectual property laws encourage pharmaceutical companies to locate their operations in the city-state. Politically, the People’s Action Party leader, Lee Hsien Loong, was installed as Prime Minister for a second term in the May 2011 general election. The Economist Intelligence Unit (EIU) projects that Singapore will rank READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aventis
  • GlaxoSmithKline
  • Merck AG
  • MerLion Pharmaceuticals
  • Pfizer
  • Wyeth
  • MORE

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

EXECUTIVE SUMMARY
Including Espicom's at a glance strategic analysis and key data projections

MACROENVIRONMENT
Political, economic, legal and demographic analysis

EPIDEMIOLOGY
Disease burden and prevalence

HEALTHCARE
Organisation, expenditure, infrastructure, services and workforce

REGULATORY AFFAIRS
Regulatory developments and marketing registration/authorisation

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET ANALYSIS
Projections, product development, manufacturing and trade

COMPETITION
Trade associations, trade fairs, company intelligence and competitive strategies

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

OPPORTUNITIES & CHALLENGES
Espicom's unique strategic analysis

DIRECTORY

METHODOLOGY & SOURCES

Note: Product cover images may vary from those shown
3 of 4

Apotheca Marketing Pte Ltd
Inchcape Marketing Services Ltd
Zuellig Pharma
DKSH Healthcare Business Unit
Drug Houses of Australia (Asia) Pte Ltd
MerLion Pharmaceuticals
Aventis
Eli Lilly
GlaxoSmithKline
Lonza Group
Merck Sharp & Dohme
Merck AG
Pfizer
Schering-Plough
Novartis
Wyeth

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db